Symbiotec Pharmalab Limited (BOM:544889)
India · Delayed Price · Currency is INR 1,130.95
-19.00 (-1.65%)
At close: Oct 7, 2026
Symbiotec Pharmalab Market Cap
Symbiotec Pharmalab has a market cap or net worth of 72.97 billion as of October 7, 2026.
Market Cap
72.97B
Enterprise Value
76.78B
Revenue
8.84B
Global Rank
n/a
Country Rank
n/a
PE Ratio
77.61
ChartMarket Cap Chart
Since September 1, 2026, Symbiotec Pharmalab's market cap has increased from 70.53B to 72.97B, an increase of 3.45%. That is a compound annual growth rate of 41.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 72.97B | -1.21% |
| Oct 6, 2026 | 73.86B | -1.73% |
| Oct 5, 2026 | 75.16B | -2.36% |
| Oct 1, 2026 | 76.98B | 1.81% |
| Sep 30, 2026 | 75.61B | 2.84% |
| Sep 29, 2026 | 73.52B | 8.38% |
| Sep 28, 2026 | 67.84B | 5.22% |
| Sep 25, 2026 | 64.47B | -2.02% |
| Sep 24, 2026 | 65.80B | -3.57% |
| Sep 23, 2026 | 68.24B | -5.25% |
| Sep 22, 2026 | 72.02B | -3.04% |
| Sep 21, 2026 | 74.28B | 5.57% |
| Sep 18, 2026 | 70.37B | 4.73% |
| Sep 17, 2026 | 67.19B | 0.27% |
| Sep 16, 2026 | 67.01B | -3.45% |
| Sep 15, 2026 | 69.40B | -4.71% |
| Sep 11, 2026 | 72.83B | -0.48% |
| Sep 10, 2026 | 73.18B | 0.46% |
| Sep 9, 2026 | 72.85B | 3.62% |
| Sep 8, 2026 | 70.30B | -0.42% |
| Sep 7, 2026 | 70.60B | 1.90% |
| Sep 4, 2026 | 69.28B | 0.13% |
| Sep 3, 2026 | 69.19B | -1.46% |
| Sep 2, 2026 | 70.22B | -0.45% |
| Sep 1, 2026 | 70.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 277.96B |
| Shilpa Medicare | 209.75B |
| Suven Life Sciences | 87.41B |
| Symbiotec Pharmalab | 72.97B |
| IOL Chemicals and Pharmaceuticals | 62.96B |
| Gujarat Themis Biosyn | 50.83B |
| NGL Fine-Chem | 19.15B |
| Bajaj HealthCare | 10.87B |